Table I.
PD | MSA | DLB | P-value | |
---|---|---|---|---|
N | 14 | 12 | 14 | |
Sex (F/M) | 4/10 | 5/7 | 4/10 | 0.12 |
Age (years) | 65 ± 6.7 | 66.9 ± 11.3 | 70 ± 7.5 | 0.34 |
Education (years) | 17.9 ± 2.8 | 15.9 ±2.8 | 16.6 ± 2.8 | 0.34 |
Disease duration (years) | 4.1 ± 3.5 | 5.4 ± 3.6 | 5.7 ± 3.5 | 0.54 |
Handedness (R/L) | 11/2 | 12/0 | 14/0 | |
Dopaminergic agent total (n) | 10 | 2 | 9 | |
L-DOPA | 9 | 2 | 8 | |
Dopamine Receptor agonist | 8 | 1 | 1 | |
Amantadine | 1 | 0 | 1 | |
Cholinesterase inhibitor (n) | 1 | 1 | 9 | |
Anti-depressant (n) | 5 | 5 | 5 | |
Anti-psychotic (n) | 0 | 1 | 3 | |
Anti-cholinergic agent | 2 | 0 | 0 |